Growth Metrics

Scholar Rock Holding (SRRK) Net Cash Flow (2017 - 2026)

Scholar Rock Holding's quarterly Net Cash Flow came in at $106.4 million in Q1 2026, up 366.19% year-on-year from $22.8 million in Q1 2025, and up 189.32% quarter-over-quarter from $36.8 million in Q4 2025.

Scholar Rock Holding has reported Net Cash Flow for 10 years, with the latest figure at $106.4 million in Q1 2026.

  • For the quarter ending Q1 2026, Net Cash Flow rose 366.19% year-over-year to $106.4 million; the trailing twelve-month figure through Mar 2026 stood at $293.4 million (up 538.46% YoY), and the FY2025 full-year result was $147.1 million, up 93.43% from the prior year.
  • Net Cash Flow for Q1 2026 stood at $106.4 million, up from $36.8 million in the prior quarter.
  • The five-year high for Net Cash Flow was $205.6 million in Q2 2022, with the low at -$172.7 million in Q3 2022.
  • Average Net Cash Flow over 5 years is $12.8 million, with a median of $1.4 million recorded in 2024.
  • Year-over-year, Net Cash Flow tumbled 8912.8% in 2022 and soared 976.74% in 2025.
  • Tracing SRRK's Net Cash Flow over 5 years: stood at -$29.8 million in 2022, then surged by 214.27% to $34.1 million in 2023, then soared by 198.04% to $101.5 million in 2024, then sank by 63.78% to $36.8 million in 2025, then surged by 189.32% to $106.4 million in 2026.
  • The last three Net Cash Flow figures came in at $106.4 million (Q1 2026), $36.8 million (Q4 2025), and $135.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 2.44 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 625.70 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -2.44 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 457.40 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -152.20 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 60.68 Mn
10 Scholar Rock Holding 500.61 Mn 20.67 Mn - 106.35 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 106.35 Mn
Mar 31, 2026 106.35 Mn
Dec 31, 2025 36.76 Mn
Dec 31, 2025 36.76 Mn
Sep 30, 2025 135.25 Mn
Sep 30, 2025 135.25 Mn
Jun 30, 2025 15.00 Mn
Jun 30, 2025 15.00 Mn
Mar 31, 2025 -39.95 Mn
Mar 31, 2025 -39.95 Mn
Dec 31, 2024 101.49 Mn
Dec 31, 2024 101.49 Mn
Sep 30, 2024 -16.98 Mn
Sep 30, 2024 -16.98 Mn
Jun 30, 2024 1.39 Mn
Jun 30, 2024 1.39 Mn
Mar 31, 2024 -9.88 Mn
Mar 31, 2024 -9.88 Mn
Dec 31, 2023 34.05 Mn
Dec 31, 2023 34.05 Mn
Sep 30, 2023 -40.47 Mn
Sep 30, 2023 -40.47 Mn
Jun 30, 2023 -43.10 Mn
Jun 30, 2023 -43.10 Mn
Mar 31, 2023 48.01 Mn
Mar 31, 2023 48.01 Mn
Dec 31, 2022 -29.80 Mn
Dec 31, 2022 -29.80 Mn
Sep 30, 2022 -172.66 Mn
Sep 30, 2022 -172.66 Mn
Jun 30, 2022 205.56 Mn
Jun 30, 2022 205.56 Mn
Mar 31, 2022 -112.66 Mn
Mar 31, 2022 -112.66 Mn
Dec 31, 2021 36.70 Mn
Dec 31, 2021 36.70 Mn
Sep 30, 2021 -30.79 Mn
Sep 30, 2021 -30.79 Mn
Jun 30, 2021 47.81 Mn
Jun 30, 2021 47.81 Mn
Mar 31, 2021 -1.25 Mn
Mar 31, 2021 -1.25 Mn
Dec 31, 2020 104.13 Mn
Dec 31, 2020 104.13 Mn
Sep 30, 2020 -58.90 Mn
Sep 30, 2020 -58.90 Mn
Jun 30, 2020 19.69 Mn
Jun 30, 2020 19.69 Mn
Mar 31, 2020 59.13 Mn
Mar 31, 2020 59.13 Mn
Dec 31, 2019 5.96 Mn
Dec 31, 2019 5.96 Mn
Sep 30, 2019 -81.16 Mn
Sep 30, 2019 -81.16 Mn
Jun 30, 2019 46.79 Mn
Jun 30, 2019 46.79 Mn
Mar 31, 2019 -48.07 Mn
Mar 31, 2019 -48.07 Mn
Dec 31, 2018 11.08 Mn
Dec 31, 2018 11.08 Mn
Sep 30, 2018 -11.08 Mn
Sep 30, 2018 -11.08 Mn
Jun 30, 2018 92.24 Mn
Jun 30, 2018 92.24 Mn
Mar 31, 2018 -33.64 Mn
Mar 31, 2018 -33.64 Mn
Dec 31, 2017 46.56 Mn
Dec 31, 2017 46.56 Mn
Sep 30, 2017 3.06 Mn
Sep 30, 2017 3.06 Mn